SpringWorks Therapeutics Inc (NASDAQ: SWTX) kicked off on Monday, up 5.00% from the previous trading day, before settling in for the closing price of $35.59. Over the past 52 weeks, SWTX has traded in a range of $28.21-$53.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -20.00%. While this was happening, its average annual earnings per share was recorded 39.57%. With a float of $65.88 million, this company’s outstanding shares have now reached $74.34 million.
Considering the fact that the conglomerate employs 305 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 93.59%, operating margin of -217.92%, and the pretax margin is -203.09%.
SpringWorks Therapeutics Inc (SWTX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of SpringWorks Therapeutics Inc is 11.43%, while institutional ownership is 101.68%. The most recent insider transaction that took place on Dec 03 ’24, was worth 839,336. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $41.97, taking the stock ownership to the 209,600 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Chief Executive Officer sold 49,000 for $41.37, making the entire transaction worth $2,027,357. This insider now owns 1,014,368 shares in total.
SpringWorks Therapeutics Inc (SWTX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.57% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
Take a look at SpringWorks Therapeutics Inc’s (SWTX) current performance indicators. Last quarter, stock had a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.73, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -2.05 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Compared to the last year’s volume of 1.01 million, its volume of 0.97 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 19.76%. Additionally, its Average True Range was 1.89.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 54.82%, which indicates a significant increase from 28.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.62% in the past 14 days, which was lower than the 45.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.34, while its 200-day Moving Average is $38.96. Nevertheless, the first resistance level for the watch stands at $38.41 in the near term. At $39.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $41.09. If the price goes on to break the first support level at $35.72, it is likely to go to the next support level at $34.08. Should the price break the second support level, the third support level stands at $33.04.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
The company with the Market Capitalisation of 2.84 billion has total of 74,386K Shares Outstanding. Its annual sales at the moment are 5,450 K in contrast with the sum of -325,100 K annual income. Company’s last quarter sales were recorded 49,300 K and last quarter income was -53,530 K.
